Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP)

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP)

05/23/2018
By Centers for Disease Control and Prevention (U.S.).

[PDF-103.71 KB]

English

Details You May Also Like

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.).
Description:

Guidance to providers regarding the use of Dolutegravir. A preliminary unscheduled analysis of data from an ongoing NIH-funded observational study in Botswana suggests that an increased risk of neural tube defects was associated with exposure to antiretroviral (ARV) regimens that include dolutegravir (DTG) at conception.
Subjects:

[+]

HIV Pregnant Women
Document Type:

Journal Article
Place as Subject:

United States
Collection(s):

Guidelines and Recommendations
Main Document Checksum:

[+]

urn:sha256:e93cfc6936403d7b3c69ff6b1fd40a1177b778b4297efcceafb9541d6a052f44
Download URL:

https://stacks.cdc.gov/view/cdc/80420/cdc_80420_DS1.pdf
File Type:

No Additional Files

More +

Interim Statement Regarding Potential Fetal Harm from Exposure to Dolutegravir – Implications for HIV Post-exposure Prophylaxis (PEP)

Details:

Supporting Files

You May Also Like